TaiMed Biologics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	18,988	16,720	23,485	20,746	17,843	17,813
Market Cap Growth	-24.92%	-28.80%	13.20%	16.27%	0.17%	-16.02%
Enterprise Value	17,838	15,456	21,842	20,859	17,860	17,487
Last Close Price	69.50	61.20	86.00	80.83	69.69	69.59
Forward PE	-	-	-	282.76	-	-
PS Ratio	31.58	27.35	38.49	42.19	31.69	43.09
PB Ratio	5.00	4.33	5.84	8.09	6.57	6.06
P/TBV Ratio	5.62	4.89	6.74	10.69	8.96	8.40
P/FCF Ratio	244.45	99.24	-	-	-	-
P/OCF Ratio	189.17	87.47	-	-	-	-
EV/Sales Ratio	29.67	25.28	35.80	42.42	31.72	42.30
EV/FCF Ratio	229.66	91.74	-	-	-	-
Debt / Equity Ratio	0.13	0.13	0.13	0.29	0.28	0.19
Debt / FCF Ratio	6.25	2.93	-	-	-	-
Net Debt / Equity Ratio	-0.30	-0.33	-0.28	0.04	0.05	-0.13
Net Debt / EBITDA Ratio	106.46	27.42	10.81	-5.89	-2.92	1.16
Net Debt / FCF Ratio	-14.79	-7.57	2.91	-3.29	-0.20	1.77
Asset Turnover	0.13	0.13	0.14	0.12	0.13	0.08
Inventory Turnover	0.23	0.24	0.28	0.20	0.27	0.27
Quick Ratio	9.39	7.48	13.26	2.31	2.32	5.12
Current Ratio	16.83	13.11	25.18	5.96	6.56	10.37
Return on Equity (ROE)	-3.22%	-4.26%	-6.13%	-7.38%	-9.52%	-14.82%
Return on Assets (ROA)	-2.08%	-2.48%	-3.55%	-2.60%	-2.75%	-6.20%
Return on Capital Employed (ROCE)	-3.60%	-4.30%	-5.20%	-4.70%	-5.10%	-11.10%
Earnings Yield	-0.66%	-1.00%	-0.86%	-0.94%	-1.51%	-2.64%
FCF Yield	0.41%	1.01%	-1.65%	-0.15%	-3.41%	-1.24%
Buyback Yield / Dilution	0.00%	-1.85%	-6.08%	-0.18%	-0.04%	-0.03%